METLIFE STATE STREET EQUITY TRUST
24F-2NT, 1995-08-25
Previous: AIRSENSORS INC, 10-K/A, 1995-08-25
Next: METLIFE STATE STREET EQUITY TRUST, DEFS14A, 1995-08-25




                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                RULE 24f-2 NOTICE

                                       FOR

                       METLIFE - STATE STREET EQUITY TRUST
                       -----------------------------------
                              (Name of Registrant)

                              One Financial Center
                           Boston, Massachusetts 02111
                           ---------------------------

            METLIFE - STATE STREET RESEARCH CAPITAL APPRECIATION FUND shares,
                                $0.001 par value

                METLIFE - STATE STREET RESEARCH EQUITY INCOME FUND shares,
                                $0.001 par value

              METLIFE - STATE STREET RESEARCH EQUITY INVESTMENT FUND shares,
                                $0.001 par value

                   STATE STREET RESEARCH GLOBAL RESOURCES FUND shares,
                                $0.001 par value

               (Title of Securities with respect to which Notice is Filed)

                            1933 Act File No. 33-4296
                           1940 Act File No. 811-4624




   
1. Fiscal year for which Notice is filed:                        June 30, 1995
    

2. Number of shares of beneficial interest of the same series which had been
   registered under the Securities Act of 1933 other than pursuant to Rule
   24f-2, but which remained unsold at the beginning of such fiscal year:

   MetLife - State Street Research Capital Appreciation Fund shares          0
   MetLife - State Street Research Equity Income Fund shares                 0
   MetLife - State Street Research Equity Investment Fund shares             0
   State Street Research Global Resources Fund shares                        0

3. Number of shares of beneficial interest, if any, registered during such
   fiscal year other than pursuant to Rule 24f-2:

   MetLife - State Street Research Capital Appreciation Fund shares          0
   MetLife - State Street Research Equity Income Fund shares                 0
   MetLife - State Street Research Equity Investment Fund shares             0
   State Street Research Global Resources Fund shares                        0



<PAGE>


4. Number of shares of beneficial interest sold during such fiscal year:

<TABLE>
  
   <S>                                                                   <C>
   MetLife - State Street Research Capital Appreciation 
    Fund shares                                                          15,050,240 (1)
   MetLife - State Street Research Equity Income Fund shares              2,408,459 (1)
   MetLife - State Street Research Equity Investment Fund shares          2,089,892 (1)
   State Street Research Global Resources Fund shares                     3,218,112 (1)

5.  Number of shares of beneficial interest sold during such fiscal year in
    reliance upon registration pursuant to Rule 24f-2:

    MetLife - State Street Research Capital Appreciation Fund shares     15,050,240 (2)
    MetLife - State Street Research Equity Income Fund shares             2,408,459 (2)
    MetLife - State Street Research Equity Investment Fund shares         2,089,892 (2)
    State Street Research Global Resources Fund shares                    3,218,112 (2)
</TABLE>


6.  The required opinion of counsel is attached hereto.

------------------

(1)   Excludes shares issued upon reinvestment of dividends and distributions.

(2)   The actual aggregate sales price for which such securities were sold was
      $148,936,300 for MetLife - State Street Research Capital Appreciation
      Fund, $26,044,013 for MetLife - State Street Research Equity Income Fund,
      $26,778,144 for MetLife - State Street Research Equity Investment Fund and
      $36,587,617 for State Street Research Global Resources Fund. During the
      fiscal year ended June 30, 1995 the actual aggregate redemption price of
      securities of the same series redeemed by the Registrant was $112,017,394
      for MetLife - State Street Research Capital Appreciation Fund, $21,041,937
      for MetLife - State Street Research Equity Income Fund, $18,933,107 for
      MetLife - State Street Research Equity Investment Fund and $38,679,308 for
      State Street Research Global Resources Fund. No portion of such aggregate
      redemption price has been applied by the Registrant pursuant to Rule
      24e-2(a) in a filing made pursuant to Section 24(e)(1) of the Investment
      Company Act of 1940. Pursuant to Rule 24f-2(c), the registration fee with
      respect to the securities sold is calculated as follows (rounded to the
      next highest dollar):

        MetLife - State Street Research Capital Appreciation Fund: $148,936,300
        - $112,017,394 = $36,918,906 (divided by) 2,900 = $12,730.66

        MetLife - State Street Research Equity Income Fund: $26,044,013 -
        $21,041,937 = $5,002,076 (divided by) 2,900 = $1,724.85

        MetLife - State Street Research Equity Investment Fund: $26,778,144 -
        $18,933,107 = $7,845,037 (divided by) 2,900 = $2,705.18

        State Street Research Global Resources Fund: $36,587,617 - $38,679,308 =
        $(2,091,691) (divided by) 2,900 = $(721.27)

        Total for MetLife - State Street Equity Trust: $238,346,074 -
        $190,671,746 = $47,674,328 (divided by) 2,900 = $16,439.42

      A certified check for the filing fee of $16,440 has been sent under
separate cover to the Commission's Mellon Bank lockbox.

Dated:  August 24, 1995

                                          MetLife - State Street Equity Trust



                                          By: /s/ Darman A. Wing
                                              ------------------
                                              Darman A. Wing
                                              Assistant Secretary




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission